This profile hasn't yet passed our validation checks
Submit your email to push it up the queue
Merial Limited
Merial Limited, a prominent player in the animal health industry, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 1997, the company has established itself as a leader in the development of innovative vaccines and pharmaceuticals for both livestock and companion animals. Merial's core product offerings include a range of vaccines, parasiticides, and diagnostic tools, which are distinguished by their efficacy and safety profiles. The company is particularly renowned for its pioneering work in the field of veterinary medicine, contributing significantly to animal health and welfare. With a strong market position, Merial has achieved notable milestones, including numerous product launches that have set new standards in the industry. As a trusted name in animal health, Merial continues to advance veterinary science, ensuring the well-being of animals worldwide.
DitchCarbon Score
How does Merial Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Merial Limited's score of 38 is higher than 62% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Merial Limited, headquartered in the US, currently does not have specific carbon emissions data available for recent years, as indicated by the absence of emissions figures. The company is a current subsidiary of Boehringer Ingelheim GmbH, which may influence its climate commitments and performance metrics. As part of its corporate family, Merial Limited's climate initiatives and reduction targets are likely aligned with those of Boehringer Ingelheim GmbH. However, specific reduction targets or achievements for Merial Limited itself have not been disclosed. The absence of data suggests that the company may still be in the process of establishing or reporting its own emissions metrics. Merial Limited's climate commitments may be informed by broader industry standards and practices, particularly those set by its parent company. As such, stakeholders should monitor developments from Boehringer Ingelheim GmbH for insights into Merial's potential future climate strategies and performance.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 289,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 273,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 3,801,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Merial Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
